Company profile
BIOFORCE NANOSCIENCES HOLDINGS, INC. CIK 1310488
Ticker
BFNH (OTC)
Industry
Laboratory Analytical Instruments
Headquarters
Virginia Beach, VA 23454
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$1.29M
Total assets
$786
Total liabilities
$619.3K
Stockholders' equity
-$618.5K
Cash & equivalents
$786
Operating income
—
Operating cash flow
-$65.2K
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-04-15. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
78,795.0%
Equity / assets
-78,695.0%
CapEx / revenue
—
Operating cash flow / net income
0.05×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$1.29M
$786
$619.3K
-$618.5K
2024
—
-$490.4K
$862
$2.30M
-$2.30M
2023
—
-$472.0K
$638
$1.82M
-$1.82M
2022
—
-$485.5K
$734
$1.35M
-$1.35M
2021
—
-$502.0K
$11.1K
$873.0K
-$861.9K
Company Details
SIC code
3826
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13D
2026-09-04
Financials filed via
Form 10-K
filed 2026-04-15
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Virginia Beach, VA 23454
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:00 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.